6,7-Dihydro-5H-pyrrolo[1,2-a]imidazol-7-yl tert-butylcarbamate

Catalog No. :
ACKJDA411
CAS No. :
2007916-11-0
Molecular Formula :
C11H17N3O2
Molecular Weight :
223.28

IUPAC Name:6,7-dihydro-5H-pyrrolo[1,2-a]imidazol-7-yl tert-butylcarbamate

6,7-Dihydro-5H-pyrrolo[1,2-a]imidazol-7-yl tert-butylcarbamate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$583.00Login to see priceInquiryInquiry
250mg95%$952.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name6,7-Dihydro-5H-pyrrolo[1,2-a]imidazol-7-yl tert-butylcarbamate
IUPAC Name6,7-dihydro-5H-pyrrolo[1,2-a]imidazol-7-yl tert-butylcarbamate
MDL No.MFCD30472123
Molecular FormulaC11H17N3O2
Molecular Weight223.28
SMILESO=C(OC1CCN2C=CN=C21)NC(C)(C)C
InChI KeyBBDVWGBOCRFMKY-UHFFFAOYSA-N
Synonym6,7-dihydro-5H-pyrrolo[1,2-a]imidazol-7-yl tert-butylcarbamate*;Carbamic acid, N-(1,1-dimethylethyl)-, 6,7-dihydro-5H-pyrrolo[1,2-a]imidazol-7-yl ester
CAS No.2007916-11-0

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACKJDA411 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACKLNE820 route compound structure diagram
    ACKLNE820112513-79-8 In Stock
  4. Then
  5. ACKJDA411 route product structure diagram
    ACKJDA4112007916-11-0
Inquiry

2. ACKJDA411 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACKLNE820 route compound structure diagram
    ACKLNE820112513-79-8 In Stock
  4. Then
  5. ACKJDA411 route product structure diagram
    ACKJDA4112007916-11-0
Inquiry

Comments (0)